ArticleDiscover oncology2026

A lipid nanoparticle-based peptide-proteolysis-targeting chimera degrades BCL6 for diffuse large B-cell lymphoma treatment.

Shiwei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.